World Health Organization Sounds Alert Over Critical Lack of Weight-Loss Medications
Fewer than one in 10 individuals who could benefit from obesity jabs including Wegovy have access to them, states the global health agency as it issues its initial guidance on the drugs.
Considering in excess of 1,000,000,000 individuals worldwide currently classified as obese, it is calling for more widespread and fairer availability to GLP-1 medication.
According to estimates, over two billion will be living with obesity by 2030 if no action is taken.
"The new guidance affirms that obesity is a chronic disease that can be addressed with holistic and continuous care," remarked the agency's head Tedros Adhanom Ghebreyesus.
Significant expense, limited production capacity, and logistical bottlenecks are major barriers to widespread availability to the treatments that can aid individuals in losing significant body mass, says the body.
Skinny Jab Scarcity
Despite the present most optimistic outlook, the supply of such drugs could only cover about 100 million people – under 10% of eligible patients, as stated by the WHO.
The guideline calls on nations and manufacturers to expand access, via approaches like licensing agreements.
Exclusive production rights on the active ingredient – the main component of a leading brand – is set to lapse in a number of countries in 2026.
How Weight-Loss Injections Operate
The injections mimick a body's own hormone to slow digestion, curb appetite and enhance satiety so individuals eat less.
Patients commonly start to lose weight in the initial weeks of starting on the regular doses.
Research indicates people may put most of the weight back on after a year of halting the treatment, as their typical food cravings resume.
To be overweight or obese elevates your likelihood for contracting diseases, like diabetes, heart disease, stroke, and certain cancers.
Excess weight impacts people in countries worldwide and was associated with over three and a half million fatalities worldwide in 2024, per the health agency.
